BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 2010

View Archived Issues

DC-based TaReNef AIDS vaccine is safe and immunogenic in phase I/II trial

Read More

Pfizer's antibacterial MC-1 shows promising preclinical activity

Read More

Snapshots: Recent data on the antibacterial activity of CXA-101

Read More

First-in-human data disclosed on NIBR-6465

Read More

Pfizer introduces new candidates for inhalation therapy of COPD

Read More

Sigma-Tau describes new adenosine A2A receptor antagonists

Read More

Prosidion discloses new GPR119 receptor agonists

Read More

Phase I/II trials suggest efficacy of Neuvax vaccine in prevention of breast cancer recurrence

Read More

Auxilium begins phase III Xiaflex studies in Peyronie's disease

Read More

FDA sets date for end-of-phase II meeting on NTx-265

Read More

State University of New York, Albany claims novel antiestrogens

Read More

Exelixis and Bristol-Myers Squibb collaborate on multiple small-molecule programs

Read More

CureVac presents phase I/IIa data on CV-9103 in prostate cancer

Read More

GSK describes new tyrosine-protein kinase ITK/TSK inhibitors

Read More

Jazz Pharma receives FDA complete response letter regarding JZP-6 for fibromyalgia

Read More

FDA approves delayed-release risedronate sodium for postmenopausal osteoporosis

Read More

Researchers synthesize new oncolytic gold complexes

Read More

Novartis to use ImmunoGen's TAP technology to develop anticancer therapeutics

Read More

Seattle Genetics reports phase II data on brentuximab vedotin in lymphoma

Read More

ArQule and Daiichi Sankyo agree with FDA on SPA for phase III ARQ-197 trial

Read More

Novo Nordisk tenders all of its shares in ZymoGenetics to Bristol-Myers Squibb

Read More

FDA approves Vivitrol for prevention of relapse to opioid dependence

Read More

Phase III Multikine trial in head and neck cancer approved in Taiwan

Read More

Jubilant Organosys becomes Jubilant Life Sciences

Read More

Lundbeck acquires exclusive commercial rights to Sycrest outside U.S., China and Japan

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 3, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing